Pubblicazioni

Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach

2018 - ANNALS OF ONCOLOGY

Falcone, R.; Paci, P.; Verrienti, A.; Fiscon, G.; Sponziello, M.; Conte, F.; Pecce, V.; Rosignolo, F.; Grani, G.; Lamartina, L.; Ramundo, V.; Durante, C.; Farina, L.; Filetti, S.

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

2017 - ANNALS OF ONCOLOGY

Ciuffreda, L; DEL CURATOLO, ANAIS; Falcone, I; Conciatori, F; Bazzichetto, C; Cognetti, F; Corbo, V; Scarpa, A; Milella, M

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

2016 - ANNALS OF ONCOLOGY

Vitolo, U.; Seymour, J. F.; Martelli, Maurizio; Illerhaus, G.; Illidge, T.; Zucca, E.; Campo, E.; Ladetto, M.; on behalf of the ESMO Guidelines Committee, Null

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

2016 - ANNALS OF ONCOLOGY

Lonardi, S.; Sobrero, A.; Rosati, G.; Di Bartolomeo, M.; Ronzoni, M.; Aprile, G.; Scartozzi, M.; Banzi, M.; Zampino, M. G.; Pasini, F.; Marchetti, P.; Cantore, M.; Zaniboni, A.; Rimassa, L.; Ciuffreda, L.; Ferrari, D.; Barni, S.; Zagonel, V.; Maiello, E.; Rulli, E.; Labianca, Roberto